Dose-finding Study With Lu AA24530 in Major Depressive Disorder
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the efficacy in treating patients with Major
Depressive Disorder of one or more doses of Lu AA24530 relative to placebo